Types of RNA therapeutics
Pouya Goleij(The University of Sydney), Hossein Motedayyen(Kashan University of Medical Sciences), Pantea Majma Sanaye(Zanjan University of Medical Sciences), Reza Arefnezhad(Shiraz University of Medical Sciences), Aryan Rezaee(Iran University of Medical Sciences), Mohammad Amin Khazeei Tabari(Universal Scientific Education and Research Network), Sarvin Sadreddini(Tabriz University of Medical Sciences), Mehregan Babamohamadi(University of Tabriz)
Cited by 14
Related Papers
Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2024|209
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
|Cell Death and Disease|2024|83
Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
|Frontiers in Molecular Biosciences|2022|31
Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin
|Leukemia Research|2024|14
Recent advances in targeting LRRK2 for Parkinson’s disease treatment
|Journal of Translational Medicine|2025|14